(Q30804635)

12 September 2017

Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. (English)

1 reference

12 September 2017

Clostridium difficile

0 references

author name string

F Barbut

1

1 reference

12 September 2017

D Decré

2

1 reference

12 September 2017

B Burghoffer

3

1 reference

12 September 2017

D Lesage

4

1 reference

12 September 2017

F Delisle

5

1 reference

12 September 2017

V Lalande

6

1 reference

12 September 2017

M Delmée

7

1 reference

12 September 2017

V Avesani

8

1 reference

12 September 2017

N Sano

9

1 reference

12 September 2017

C Coudert

10

1 reference

12 September 2017

J C Petit

11

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Antimicrobial Agents and Chemotherapy

12 September 2017

1 reference

12 September 2017

43

1 reference

12 September 2017

11

1 reference

12 September 2017

2607-2611

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Use of an enzyme-linked immunoassay for Clostridium difficile serogrouping

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Clostridium difficile colonization and diarrhea at a tertiary care hospital

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Clostridium difficile colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Antimicrobial susceptibility of Clostridium difficile determined by disc diffusion and breakpoint methods.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Nosocomial acquisition of Clostridium difficile infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Evaluation of the E test for susceptibility testing of anaerobic bacteria

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococi, enterococci and Clostridium difficile

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Antimicrobial susceptibility of Clostridium difficile strains isolated from hospitalised patients with acute diarrhoea

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Susceptibility testing of anaerobes with Etest.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Management and control of a large outbreak of diarrhoea due to Clostridium difficile

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Comparison of the E test and a reference agar dilution method for susceptibility testing of anaerobic bacteria

25 November 2018

1 reference

12 December 2020

Investigation of a nosocomial outbreak of Clostridium difficile-associated diarrhoea among AIDS patients by random amplified polymorphic DNA (RAPD) assay

1 reference

12 December 2020

Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin

1 reference

12 December 2020

Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study

1 reference

12 December 2020

Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations

1 reference

12 December 2020

Susceptibility of Clostridium difficile strains to new antibiotics: quinolones, efrotomycin, teicoplanin and imipenem

1 reference

12 December 2020

Epidemiology and prevention of Clostridium difficile infections in a leukemia unit

1 reference

12 December 2020

In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria

1 reference

12 December 2020

Identifiers

1 reference

12 September 2017

PubMed publication ID

10543736

1 reference